Quick answer. There is no single price for cancer treatment in Singapore – it varies enormously by cancer type, stage and the specific drugs used, ranging from a few hundred dollars for some subsidised chemotherapy cycles to tens of thousands for surgery, radiotherapy or newer drug regimens. Since the 2022-2023 cancer financing changes, MediShield Life and MediSave only cover OUTPATIENT cancer DRUGS that are on the MOH Cancer Drug List (CDL), each with its own monthly claim limit, plus a separate annual limit for cancer drug services (scans, blood tests, consults); drugs not on the CDL cannot be claimed from MediShield Life or MediSave. Subsidised treatment at public centres (NCCS, NCIS) is far cheaper than private, and Integrated Shield Plan coverage for cancer drugs is also CDL-based (often with rider multipliers). A hospital financial counsellor or medical social worker can map your costs, and MediFund is a safety net for those who still cannot afford their bills.
Cancer treatment in Singapore can cost anywhere from a few hundred dollars per chemotherapy cycle in a subsidised setting to well over S$100,000 a year for advanced drug regimens in private care. How much you actually pay depends on your cancer type and stage, the treatments needed (surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy or hormonal therapy), whether you are treated as a subsidised public patient or a private patient, and crucially whether your drugs appear on the MOH Cancer Drug List. This guide explains the typical cost picture and exactly how MediSave, MediShield Life, Integrated Shield Plans and government safety nets apply in 2026.
At a glance
| Treatment / pathway | Typical cost | Financing notes |
|---|---|---|
| Chemotherapy (subsidised, public) | From ~S$13 to ~S$700+ per cycle depending on regimen (e.g. ~S$2,800 total for a 4-cycle breast regimen, unsubsidised estimate) | Outpatient CDL drugs claimable from MediShield Life/MediSave up to each drug's monthly limit; services (scans, consults) up to S$3,600/yr MediShield Life + S$600/yr MediSave |
| Chemotherapy (private) | Substantially higher; varies by drug and number of cycles | CDL-listed drugs claimable up to MediShield Life limit; IP riders may pay ~15x-21x that limit for CDL drugs |
| Radiotherapy course | Roughly S$20,000-S$30,000 | Inpatient/related costs under standard MediShield Life and IP limits; ask centre for bill estimate |
| Cancer surgery | From a few thousand dollars (subsidised ward) to S$30,000+ (private) for the same procedure | Surgical costs covered under standard inpatient MediShield Life/MediSave and IP limits, not the CDL |
| Targeted therapy / immunotherapy | Can add tens of thousands of dollars per year | Claimable only if the specific treatment is on the CDL, up to its monthly limit; non-CDL drugs not claimable from MediShield Life/MediSave |
| Non-CDL drugs | Variable, often very high | Not claimable from MediShield Life/MediSave; some IP riders provide a separate annual sum (e.g. ~S$150,000-S$250,000/yr); MediFund may help eligible patients |
What drives the cost of cancer treatment
Cancer is not one disease and there is no single bill. Costs are driven by several factors stacked together:
- Treatment type. Most patients need a combination of surgery, chemotherapy, radiotherapy, and increasingly targeted therapy, immunotherapy or hormonal therapy. Newer targeted and immunotherapy drugs are typically the most expensive components.
- Cancer type and stage. An early-stage cancer treated with surgery alone costs far less than an advanced cancer requiring months of drug therapy and radiotherapy.
- Specific drugs and regimen. Two patients with the same cancer can have very different bills depending on which drugs are prescribed and for how long.
- Subsidised vs private. This is often the single biggest factor. Subsidised treatment at public cancer centres can be a small fraction of private-hospital prices.
Because of this, you should treat any figure below as an indicative range, not a quote. Always ask for a written bill estimate for your specific plan.
Typical cost ranges in Singapore
Public cancer centres publish indicative bill estimates. For example, the National University Cancer Institute, Singapore (NCIS) lists out-of-pocket chemotherapy estimates for unsubsidised Singaporean patients such as roughly S$700 per cycle (about S$2,800 total) for a 4-cycle breast cancer regimen, and as little as about S$13 per cycle for a capecitabine-based colorectal regimen – figures that exclude consultations, scans and lab tests, and change with the drugs used.
Other commonly cited ranges include radiotherapy courses in the region of S$20,000-S$30,000, and cancer surgery that can run from a few thousand dollars in a subsidised public ward to well over S$30,000 in a private hospital for the same procedure. Subsidies at public institutions apply to eligible Singapore Citizens and Permanent Residents who are not existing private patients for the same condition. Newer targeted and immunotherapy drugs can add tens of thousands of dollars per year. The takeaway: the same diagnosis can produce wildly different bills, so the financing rules below matter enormously.
How MediSave, MediShield Life and the Cancer Drug List work
Singapore restructured cancer drug financing to keep drug prices in check. The key change: since 1 September 2022, MediShield Life and MediSave only cover outpatient cancer drug treatments that are on the MOH Cancer Drug List (CDL).
What the CDL is. The CDL is MOH’s published list of outpatient cancer drug treatments assessed as clinically proven and cost-effective. Each listed treatment is assigned a category with its own monthly MediShield Life claim limit (limits range from around S$200 up to several thousand dollars a month depending on the drug) and a corresponding MediSave withdrawal limit. The list is reviewed and updated about three times a year, so you should always check the current version.
Cancer drug services limit (separate). On top of the drug limits, there is a separate annual limit for cancer drug services – scans, blood tests, doctor consultations, chemotherapy preparation/administration and supportive-care drugs. Since 1 April 2023, MediShield Life covers up to S$3,600 per calendar year for these services, with up to S$600 per calendar year claimable from MediSave.
Non-CDL drugs are not claimable. If a prescribed drug is not on the CDL, it cannot be claimed from MediShield Life or MediSave – you (or an Integrated Shield Plan rider, see below) would have to fund it. Inpatient cancer drug treatment is handled under the standard inpatient limits rather than the CDL.
Integrated Shield Plans, riders and additional coverage
Integrated Shield Plans (IPs) aligned with the CDL from 1 April 2023 (upon policy renewal or application). For drugs on the CDL, IPs typically pay a multiple of the MediShield Life limit – many insurers’ optional riders offer roughly 15x to 21x the MediShield Life limit for CDL drugs, which substantially raises your claimable amount.
Some riders also add a separate annual sum for non-CDL drugs (commonly in the range of S$150,000-S$250,000 per year, depending on insurer and plan) – valuable because non-CDL drugs are otherwise not claimable from MediShield Life or MediSave. Coverage varies widely between insurers and plan tiers, so check your specific policy wording.
Note a broader 2026 change to IP riders: from 1 April 2026 new IP riders can no longer cover the annual deductible, and co-payment caps are being adjusted (capped at S$6,000). This affects how much you pay out of pocket overall, so review your rider terms.
Subsidies, MediFund and getting help with your bill
Several layers of help exist beyond insurance:
- Government subsidies. Eligible Singapore Citizens and PRs receive means-tested subsidies on treatment at public cancer centres (NCCS, NCIS and restructured hospitals), which is why subsidised care is far cheaper than private.
- MediFund. A government endowment fund acting as the safety net for Singaporeans who, after subsidies, MediShield Life and MediSave, still cannot afford their bills. Applications are made through the hospital’s medical social worker.
- Charity and assistance schemes. Organisations such as the Singapore Cancer Society offer support, and public institutions have programmes like the Medication Assistance Fund for selected drugs.
- Financial counsellors and medical social workers. Every public cancer centre has financial counsellors who can give you a personalised bill estimate, confirm whether your drugs are on the CDL, and apply MediSave/MediShield Life/IP coverage correctly. Tools like NCIS’s ChemoCalc can also estimate out-of-pocket costs.
The single most useful step for most patients is to speak to a financial counsellor or medical social worker early, before treatment starts, so there are no surprises.
Related guides
- Best Oncology Clinics in Singapore — our editorial shortlist
- oncology clinics directory
- Cancer screening by age & sex
- Breast cancer screening & mammograms
- Cancer warning signs & when to see a doctor
Sources
- MOH – Cancer Drug List
- MOH – FAQs on cancer treatment financing
- MOH – Higher MediShield Life claim limit for cancer drug services
- CPF Board – What MediShield Life covers you for
- NCIS – Chemotherapy Bill Estimates
- NCCS – Outpatient Charges
See also
Related conditions & guides
Related conditions and guides you may find useful:
- Colorectal (Bowel) Cancer in Singapore
- Liver Cancer Screening in Singapore
- Lung Cancer in Singapore
- Nasopharyngeal Cancer (NPC) in Singapore
- Prostate Cancer in Singapore
- Skin Cancer & Melanoma in Singapore
Part of our Cancer care & screening guides · Browse all health topics